ADNP ‐Related Helsmoortel–Van der Aa Syndrome: A Review of the Literature and Clinical Recommendations for Assessment and Monitoring

{"ADNP-related":[0,33,108,174,236,258],"Helsmoortel-Van":[1],"der":[2,157],"Aa":[3,158],"syndrome":[4,81],"(ADNP-related":[5],"HVDAS)":[6],"is":[7,35],"a":[8,38],"single":[9],"gene":[10],"form":[11],"of":[12,41,60,92,103,107,173,193,222,235,257,263],"autism":[13],"spectrum":[14],"disorder":[15],"(ASD)":[16],"caused":[17],"by":[18,121,133,144,216,232],"pathogenic":[19],"sequence":[20],"variants":[21],"in":[22,54,247],"the":[23,80,104,189,233,254,261],"activity-dependent":[24],"neuroprotective":[25],"protein":[26],"(ADNP)":[27],"gene.":[28],"In":[29],"addition":[30],"to":[31,51,85,96],"ASD,":[32],"HVDAS":[34,175,237,259],"associated":[36],"with":[37,79,188],"wide":[39],"range":[40],"cognitive,":[42],"behavioral,":[43],"and":[44,56,67,82,88,115,128,148,155,176,204,214,228,238,260,268],"physical":[45],"health":[46],"features":[47],"that":[48,117],"may":[49],"lead":[50],"profound":[52],"impairment":[53],"functioning":[55],"significantly":[57],"impact":[58],"quality":[59],"life":[61],"for":[62,113,125,136,211],"affected":[63,137],"individuals,":[64],"their":[65,126],"families,":[66],"caregivers.":[68],"However,":[69],"because":[70],"it":[71],"remains":[72],"rare,":[73],"most":[74],"clinicians":[75,134],"are":[76,95],"not":[77,182,226],"familiar":[78],"lack":[83],"knowledge":[84],"guide":[86],"assessment":[87,114,224],"monitoring.":[89],"The":[90],"goals":[91],"this":[93],"study":[94],"(1)":[97],"provide":[98],"an":[99],"updated":[100,251],"systematic":[101],"review":[102,141,252],"clinical":[105,171,217],"manifestations":[106,172],"HVDAS,":[109],"(2)":[110],"establish":[111],"recommendations":[112],"monitoring":[116],"can":[118],"be":[119,130],"used":[120],"caregivers":[122],"when":[123],"advocating":[124],"children,":[127],"(3)":[129],"applied":[131],"practically":[132],"caring":[135],"individuals.":[138],"A":[139,191,219],"literature":[140],"was":[142,225],"conducted":[143],"searching":[145],"PubMed,":[146],"PsycInfo,":[147],"Embase":[149],"databases":[150],"using":[151],"\\"ADNP\\",":[152],"\\"ADNP":[153],"Syndrome,\\"":[154],"\\"Helsmoortel-Van":[156],"Syndrome\\"":[159],"through":[160],"July":[161],"18,":[162],"2026.":[163],"Articles":[164],"were":[165,177,209,230],"included":[166],"if":[167,179],"they":[168,180],"reported":[169],"on":[170],"excluded":[178],"did":[181],"describe":[183],"at":[184],"least":[185],"one":[186],"individual":[187],"diagnosis.":[190],"total":[192],"28":[194],"publications":[195],"met":[196],"inclusion":[197],"criteria":[198],"including":[199],"case":[200,202],"reports,":[201],"series,":[203],"small":[205,240],"cohort":[206],"studies;":[207],"data":[208],"extracted":[210],"209":[212],"cases":[213],"organized":[215],"domain.":[218],"formal":[220],"risk":[221],"bias":[223],"performed,":[227],"results":[229],"limited":[231],"rarity":[234],"thus":[239],"sample":[241],"sizes,":[242],"as":[243,245],"well":[244],"variability":[246],"symptom":[248],"reporting.":[249],"Our":[250],"highlights":[253],"complex":[255],"symptomatology":[256],"importance":[262],"early":[264],"diagnosis,":[265],"comprehensive":[266],"evaluations,":[267],"individualized":[269],"treatment":[270],"planning.":[271]}

Authors

Institutions

Publication Details

Journal
American Journal of Medical Genetics Part A
Published
2026-09-17
DOI
https://doi.org/10.1002/ajmg.a.70288
Primary Topic
Neuropeptides and Animal Physiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

ADNP ‐Related Helsmoortel–Van der Aa Syndrome: A Review of the Literature and Clinical Recommendations for Assessment and Monitoring

Alexander Kolevzon, Jarrett Fastman, Paige M. Siper, William E. Bennett et al.
American Journal of Medical Genetics Part A
Neuropeptides and Animal Physiology
article

ADNP ‐Related Helsmoortel–Van der Aa Syndrome: A Review of the Literature and Clinical Recommendations for Assessment and Monitoring

Alexander Kolevzon, Jarrett Fastman, Paige M. Siper, William E. Bennett, Jeffrey M. Saland, Tess Levy, Sandra Bedrosian Sermone, Bruce D. Gelb, Robert Rapaport, Yitzchak Frank, Kayla Kupietzky, Ana Kolevzon
article en

Abstract

ADNP-related Helsmoortel-Van der Aa syndrome (ADNP-related HVDAS) is a single gene form of autism spectrum disorder (ASD) caused by pathogenic sequence variants in the activity-dependent neuroprotective protein (ADNP) gene. In addition to ASD, ADNP-related HVDAS is associated with a wide range of cognitive, behavioral, and physical health features that may lead to profound impairment in functioning and significantly impact quality of life for affected individuals, their families, and caregivers. However, because it remains rare, most clinicians are not familiar with the syndrome and lack knowledge to guide assessment and monitoring. The goals of this study are to (1) provide an updated systematic review of the clinical manifestations of ADNP-related HVDAS, (2) establish recommendations for assessment and monitoring that can be used by caregivers when advocating for their children, and (3) be applied practically by clinicians caring for affected individuals. A literature review was conducted by searching PubMed, PsycInfo, and Embase databases using "ADNP", "ADNP Syndrome," and "Helsmoortel-Van der Aa Syndrome" through July 18, 2026. Articles were included if they reported on clinical manifestations of ADNP-related HVDAS and were excluded if they did not describe at least one individual with the diagnosis. A total of 28 publications met inclusion criteria including case reports, case series, and small cohort studies; data were extracted for 209 cases and organized by clinical domain. A formal risk of bias assessment was not performed, and results were limited by the rarity of ADNP-related HVDAS and thus small sample sizes, as well as variability in symptom reporting. Our updated review highlights the complex symptomatology of ADNP-related HVDAS and the importance of early diagnosis, comprehensive evaluations, and individualized treatment planning.

American Journal of Medical Genetics Part A
Pitzer College (US), Child Health and Development Institute (US), Indiana University – Purdue University Indianapolis (US), Barnard College (US), Icahn School of Medicine at Mount Sinai (US)
Beatrice and Samuel A. Seaver Foundation
Reduced inequalities
Openalex Percentile: Top 17%
Neuropeptides and Animal Physiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.